Viral Infections & Inflammation Workshop
Meeting category
Date(s)
6 Sep 2023 - 7 Sep 2023
Program Language
English
Location
Rockville, MD, United States
Meeting type
Hybrid Meeting

Viral Infections & Inflammation Workshop 2023

Related Enduring Materials

Enduring Materials
5 Key Messages from VII Workshop 2022
  1. Acute and chronic effects of viral diseases often involve immune-mediated responses, including inflammation, immune activation, and autoimmunity. Therapeutic interventions must often target both ends of the virus-immune system spectrum.
  2. Statins reduce severe cardiovascular events in people with HIV, even in individuals with low baseline cardiovascular risk.
  3. Long-COVID immunopathogenesis is complex but its understanding is advancing rapidly. The consequences of immune-mediated damage in long COVID share similarities (and differences) with other post-viral diseases like Ebola and MF/CFS
  4. Viruses can also trigger autoimmunity. Epstein-Barr Virus is tightly linked with the onset of Multiple Sclerosis through several autoimmune mechanisms. Viral encephalitis also often has an autoimmune background
  5. Immune therapies targeting the inflammasome or virus-specific CAR-T cells, among others, are advancing towards the cure of different acute and chronic viral diseases 
Program
Day 1, Wednesday 6 September
Opening of the Workshop -
Plenary Talk: Update on the REPRIEVE Trial to Prevent Cardiovascular Events in People with HIV
Steven Grinspoon, MD
Harvard Medical School / Massachusetts General Hospital, United States
Session 1: Post-COVID Syndromes -
Viruses, Immune Dysfunction, and ME/CFS
Maureen R. Hanson, Ph.D.
Cornell University, United States
Underlying Mechanisms of Long COVID
Michael Peluso, MD
University of California, San Francisco, United States
(O_#1) High Levels of Il-1β, Tnf-α and Mip-1α One Month after the Onset of the Acute Sars-CoV-2 Infection, Predictors of Post COVID-19 in Hospitalized Patients
Jacobo Alonso-Domínguez
Galicia Sur Health Research Institute, Spain
(O_#2) Determinants of the Onset and Prognosis of the Post-COVID-19 Condition: A 2-Year Prospective Cohort Study
Roger Paredes
Irsicaixa Aids Research Institute, Spain
Satellite Symposium -
The Impact of Viral Glycoproteins on Inflammation and Immunity
Session 2: Post-infectious Syndromes -
Immune Signatures in Vaccine-Associated Myocarditis
Anis Barmada, MPhil
Yale University School of Medicine, United States
What We Know Now about HIV and Long COVID
Annie Antar, MD, PhD
Johns Hopkins University School of Medicine, United States
Epstein–Barr Virus and Multiple Sclerosis: Which Mechanisms are at Play?
Tobias Lanz, MD
Stanford University, United States
(O_#3) A Role for Inflammasome Activation and Oxidative Stress in Sars-CoV-2 Breakthrough Infection and Symptomatic Rebound
Silvia Lucena Lage
NIH, United States
Day 2, Thursday 7 September
Session 3: Post-acute Sequelae Following Different Infections -
Post-acute Sequelae following Ebola infection
David Wohl, MD
UNC School of Medicine, United States
Endogeneous Retroviruses and Inflammation
Yasmine Belkaid, PhD
NIH/NIAID, United States
(O_#4) HIV Exposed Uninfected (Heu) Infants Have Pro-inflammatory Bioprofiles That Correlate with Their Mothers’ Bioprofiles Independent of Viral Levels and Persist for at Least Six Months
Li Yin
NIAID, United States
(O_#5) Possible Role of Intestinal Damage and Endotoxemia in the Development of Endotholial Dysfunction, Thrombosis and Secondary Lung Damage in Patients with COVID-19
Liudmyla Shostakovych-Koretskaya
Dnipropetrovsk State Medical University, Ukraine
Session 4: Chronic Viral Infections and Inflammation-related Comorbidities -
HIV, Inflammation, and Macrophages
Maureen M. Goodenow, Ph.D.
NIAID/NIH, United States
Inflammation in People with Low Nadir CD4 Counts
Irini Sereti, MD
NIAID/NIH, United States
Acute Disseminated Encephalomyelitis
Arun Venkatesan, MD PhD
Johns Hopkins University School of Medicine, United States
(O_#6) The Plasma Microbiome Contributes to Immune Reconstitution in HIV Infected Individuals on Suppressive ART
Wei Jiang
Medical University of South Carolina, United States
Session 5: Interventions Targeting Inflammation and Post-viral Syndromes -
Inflammasome Activation in Severe Cases of COVID-19
Dario Zamboni, Ph.D.
University of São Paulo, Brazil
Developing CAR T Cells for Use in Chronic HIV Infection
Martin Tolstrup, MSc, PhD
Aarhus University Hospital, Denmark
(O_#7) Impact of Glatiramer Acetate Treatment in SIVmac-Infected Macaques
Beatrice Jacqulin
Institut Pasteur, France
Language
Ratings previous edition
Content is relevant to my practice
4.8
Content is presented clearly
4.9
The activity is well-planned
4.8
Content is free from commercial bias
4.7